USL

Arezzo, Italy
Arezzo, Italy
SEARCH FILTERS
Time filter
Source Type

To kick things off, the brand has partnered with local radio stations KUBL and KBEE to offer ten of Real Salt Lake's biggest fans a VIP Experience at Rio Tinto Stadium. Starting April 3, listeners will get the chance to win special access to the May 6 game against FC Dallas™, which will include tickets for one adult and one child (between ages five and 16), dinner at the AFCU Pavilion, pre-game sideline passes and a post-game autograph session. Even more, one lucky Grand Prize winner will get his or her moment in the spotlight at a post-game press conference, acting as a reporter and asking their favorite player a single question. Fans can also enter to win at http://www.rsl.com/post/2017/04/21/enter-win-vip-experience-cache-valley-creamery. "It is an honor to work with the Real Salt Lake organization," said Flavia Panza, Senior Marketing Director for Cache Valley Creamery. "Utah is the heart of our brand, and we look forward to strengthening our relationship with the community by joining in on the fun of the 2017 soccer season." Throughout the season, RSL fans can enjoy melt-in-your-mouth Royal Grilled Cheese sandwiches made with Cache Valley Slices at in-stadium concessions, as well as engage with the brand on a Mini Foot-Golf course complete with cheese-themed obstacles at Carnival Real, just outside Rio Tinto Stadium. At select games, attendees will also have the chance to sample Cache Valley String Cheese and take a spin at the Cache Valley Cheese Wheel to win soccer jerseys, water bottles and more. Later in the summer, fans will enjoy even more halftime fun and must-see promotions presented by Cache Valley around Father's Day and back-to-school. Since 1937, Cache Valley® Creamery has been offering delicious cheese and butter using only the highest-quality ingredients to Utahans and surrounding areas. Dedication to quality means consumers can expect wholesome, expertly crafted cheese every time.Cache Valley Creamery products are sold at retailers throughout Utah, including Walmart, Smith's, Macey's, Fresh Market, Harmon's and more. Real Salt Lake recently kicked off its 13th Major League Soccer season in 2017, the Utah side buoyed by a passionate fan base boasting nearly 13,000 season ticket holders at its Rio Tinto Stadium home in Sandy, where the "Claret-and-Cobalt" has enjoyed a most pronounced home-field advantage in Major League Soccer, posting an impressive 97-22-39 mark in the building since its opening in October, 2008. In search of hardware, RSL seeks to reach the MLS Cup Playoffs for the ninth time in 10 years this season, a remarkable run among Major League Soccer's elite that includes an MLS Cup 2009 title, the state of Utah's only major professional championship in the last 40 years. Recent campaigns have seen RSL advance to another MLS Cup title game, losing in 2013 via a penalty-kick shootout in Kansas City, where the 2015 squad also dropped a Semifinal match in the Lamar Hunt U.S. Open Cup. RSL lost an Open Cup Final at home in 2013, the one-goal loss to D.C. United a bitter reminder of the Club's groundbreaking (and ultimately heartbreaking) run to the CONCACAF Champions League Final in 2011, when the club became the first-ever – and still only – U.S. side to progress within one goal of advancing to the FIFA Club World Cup. Opening in Fall, 2017, Real Salt Lake's regional training campus arrives in Herriman, Utah, approximately 20 minutes southwest of Rio Tinto Stadium. The $60 million facility will serve as the daily training home beginning in 2018 for both of the club's professional teams – RSL (MLS) and Real Monarchs (USL) – while centralizing the club's U-18, U-16 and future U-14 development academy youth selections. The Herriman facility will provide adjacencies for an on-site charter school opening this September with STEM disciplines (Science/Technology/Engineering/Math) for nearly 300 boys and girls. Late last year in North Logan, Utah, RSL Owner Dell Loy Hansen broke ground on the first of a half-dozen regional training centers across Utah and Arizona to be built in the next 2-3 years. Each $5 million RTC houses a classroom, as well as an indoor and outdoor field, dedicated to fulfilling a curriculum consistent with the club's vision and mission for youth soccer training and education, and the continued development of both recreational and competitive pre-Academy (ages 7-12) initiatives across Utah and Arizona. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cache-valley-creamery-partners-with-real-salt-lake-for-a-season-full-of-family-friendly-events-300447663.html


FC Anahuac, Moreno Valley FC and L.A. Wolves FC All Win First Round Games -- The United Premier Soccer League (UPSL) will have three teams playing in the Second Round of the 2017 Lamar Hunt U.S. Open Cup.FC Anahuac, Moreno Valley Futbol Club and L.A. Wolves FC all had victories during the U.S. Open Cup First Round on Wednesday, May 10, and will move on to play in the tournament's Second Round next week.United Premier Soccer League Commissioner Yan Skwara said, "The Lamar Hunt U.S. Open Cup is an amazing opportunity for clubs in the UPSL. We had five UPSL member clubs qualify and are proud of the performances of each and every one. Three move on now, and that's the way it goes in a single-elimination tournament."FC Anahuac, the UPSL's 2016 Fall Season champion, went to overtime vs. Sonoma County Sol (NPSL) only to go down, 1-0, in the 100th before scoring an equalizer and winning, 5-4, in a shootout at Santa Rosa (Calif.) Elsie Allen High School. FC Anahuac next plays Sacramento Republic FC (USL).Moreno Valley Futbol Club, the 2016 USASA Region IV champion, went up two goals before halftime and held on to win, 2-1, over Ventura County Fusion (PDL) at Ventura (Calif.) College Sportsplex. Moreno Valley FC next plays OKC Energy (USL).L.A. Wolves FC, currently coached by U.S. Soccer Hall of Famer Eric Wynalda, took a 1-0 lead before halftime on a goal from Chuck Pitts, and added three more in the second half to top San Diego Zest FC (PDL), 4-2, at Azusa (Calif.) Pacific University's Cougar Soccer Complex. L.A. Wolves FC next plays Chula Vista FC (SoCal Premier).Colorado Rush, which qualified for the U.S. Open Cup before joining the UPSL Colorado Conference for its inaugural 2017 Spring Season, traveled to FC Tucson (PDL) but lost, 3-1, at King Sports Complex in Tucson (Ariz.).La Maquina FC, which reached the Fourth Round of the 2016 U.S. Open Cup tournament before losing in OT to Los Angeles Galaxy (MLS), traveled to Chukchansi Park in Fresno, Calif., but lost, 4-1, to Fresno Fuego (PDL).The UPSL was formed in 2011 and currently includes more than 60 teams in Arizona, California, Colorado, Florida, Idaho, Nevada, New York, North Carolina and Utah. The UPSL is the fastest growing Pro Development League in the USA, with 80-plus teams targeted for 2018 Spring Season. Each UPSL team is individually owned and operated, and is responsible for maintaining UPSL Pro Premier Division and Championship Division minimum standards.UPSL teams are all eligible to participate in the U.S. Open Cup Qualifying Rounds through the leagues affiliation with the U.S. Soccer Federation (USSF) and the United States Adult Soccer Association (USASA).More information about UPSL can be found at www.upslsoccer.com or by following the league on Facebook (www.facebook.com/upslsoccer) and Twitter (@upslsoccer)Contact UPSL:info@upslsoccernews.comDirect: 310-415-5691Media Relations:Dennis Popedennis.pope@upslsoccernews.comDirect: 951-675-3963www.twitter.com/unitedpremiersoccerleague


News Article | May 29, 2017
Site: www.prnewswire.com

LONDON, May 29, 2017 /PRNewswire/ -- According to Stratistics MRC, the Global Solar Pumps market is expected to grow from $0.027 billion in 2016 to reach $0.148 billion by 2022 with a CAGR of 32.2%. Growing customer preferences towards solar pumps rather than diesel pumps and raising demand for automated pump systems are some of the factors fuelling the market growth. In addition, due to less availability of its spare parts whenever required and huge capital investment are hindering the growth of the market. Download the full report: https://www.reportbuyer.com/product/4917242/ Based on the application segment, agriculture industry leads the market globally as solar pumps are used where there is water scarcity, insufficient electricity and erratic rainfall. However, in product segment the demand for AC submersible pumps is growing rapidly as it is intended to supply groundwater from boreholes and deep wells. Asia Pacific is expected to witness huge growth due to increasing number of photovoltaic installations in China. Some of the key players in global Solar Pumps market include USL, Bright Solar Water Pumps, Tata Power Solar Systems Ltd, CRI Group, Solar Power & Pump Co., LLC, Rainbow Power Co Ltd, American West Windmill & Solar Company, Grundfos, Wenling Jintai Pump Factory, SunEdison, Shakti Solar Pumping System, Lorentz, Greenmax Technology, Conergy, Dankoff Solar, Greenmax Technology and Flowserve. Applications Covered: - Drinking water - Agriculture - Other Applications o Oil & gas o Chemical Product Types Covered: - Alternating Current(AC) AC Floating - Direct Current (DC) surface pump or floating pump set - DC Submersible - AC surface or submersible pump set Regions Covered: - North America o US o Canada o Mexico - Europe o Germany o France o Italy o UK o Spain o Rest of Europe - Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific - Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements Download the full report: https://www.reportbuyer.com/product/4917242/ About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers http://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: query@reportbuyer.com   Tel: +44 208 816 85 48 Website: www.reportbuyer.com To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/solar-pumps---global-market-outlook-2016-2022-300465058.html


REDWOOD CITY, Calif., May 9, 2017 /PRNewswire/ -- C2 Therapeutics marked Digestive Disease Week by releasing the results of clinical studies that help further validate the utility of the C2 CryoBalloon® Ablation System (CbAS) for ablation of Barrett's esophagus.i These include studies that suggest a shorter physician learning curve with CbAS than for radiofrequency ablation (RFA) therapy and less pain two days post-procedure than with RFA. Further studies demonstrate potential for CbAS in ablation of gastric antral vascular ectasia (GAVE) and esophageal squamous cell neoplasia (ESCN). The CbAS is similar to RFA in being deployed with an endoscopic catheter but uses extreme cold instead of heat to destroy diseased tissue in the esophagus. In a procedure known as cryoballoon ablation, nitrous oxide (N 0) cryogen is delivered through a handheld controller in combination with a self-sizing balloon catheter that is inserted into the working channel of a 3.7 mm therapeutic endoscope. The CbAS has been used in nearly 900 procedures to date. The synopses of the study results released for Digestive Disease Week are: Physician Learning Curve. Studies show that physicians must perform about 30 RFA procedures to overcome the effect of learning curve on treatment outcomes.1 This study aimed to determine the learning threshold for ablation of Barrett's esophagus with the CbAS. The researchers analyzed prospectively collected cryoablation procedure data from patients with neoplastic Barrett's esophagus treated at a single academic institution. They concluded that the learning curve effect for CbAS is reached at about 18 cases, after which efficiency plateaus. Patient Experience. Two studies in the Netherlands2 compared post-procedural pain in 79 Barrett's esophagus patients treated with RFA patients and 20 treated with focal cryoballoon ablation. In both studies, all visible Barrett's esophagus was treated, including circumferential treatment of the gastroesophageal junction. Pain was assessed immediately after the procedures and by telephone on Day 2. Patients were asked to apply pain scores from zero (no pain) to 10 (worst pain possible). Immediately after the procedure, 53% of cryoballoon ablation patients reported severe pain (score greater than 3), versus 24% of RFA patients. However, on Day 2, 46% of RFA patients reported severe pain, versus 18% of cryoballoon ablation patients. "This could suggest a shortened pain course after cryoballoon ablation compared with RFA," said the principal investigator Prof. Bas Weusten, Gastroenterology & Hepatology, St. Antonius Hospital, Nieuwegein, Netherlands. Treatment for ESCN. Esophageal squamous cell cancer arises from esophageal squamous cell neoplasia (ESCN) and is highly lethal. A multi-site study3 assessed the safety and efficacy of focal cryoballoon ablation for eradicating ESCN. Forty-two patients (98%) were successfully treated. Thirty-five of 40 patients (88%) had complete eradication of unstained lesions (USL) upon a single treatment session; five patients (12%) with persistent USL were successfully re-treated. Three developed superficial self-limited mucosal laceration upon balloon inflation; two of these were successfully treated three months later and one did not return. Dr. Gui-Qi Wang, Department of Endoscopy, Cancer Institute and Hospital Chinese Academy of Medical Sciences in Beijing, China stated, "Although longer-term follow-up data is pending, early results of our multicenter study suggest that focal cryoballoon ablation is safe, well-tolerated and highly effective in inducing complete endoscopic and histologic response." Treatment for GAVE. GAVE is an uncommon cause of upper gastrointestinal bleeding. Endoscopic management has been mainly thermoablative, but balloon cryoablation is emerging as an alternative. This multi-center study4 reviewed data from 10 patients with refractory GAVE who were treated with balloon cryotherapy. These were patients who continued to receive treatment for GAVE despite prior non-cryoballoon therapy. Each patient received one to four cryoballoon treatments (median two). Technical success was achieved in all patients. Follow-up endoscopy showed improvement in eight patients; one patient showed no improvement in the three months post-cryotherapy. No adverse events were reported. "Cryoballoon therapy is a feasible and safe modality that can be used to treat GAVE," reports Dr. Amrita Sethi, Division of Digestive and Liver Disease, Columbia University Medical Center, New York, NY. "Further studies are needed to evaluate long-term outcomes for this modality and to compare results to standard therapies." Swipe Cryoballoon Ablation Technique. Ablation devices for dysplastic Barrett's esophagus are effective, but none offer the attributes for widespread adoption because of length of procedure time and ease of use. Other factors include side effects and lack of predictability of ablation depth. This multi-center study5 evaluated the safety, feasibility and dose response of a novel swipe balloon catheter developed by C2 Therapeutics (to be marketed as the C2 CryoBalloon® 90 Ablation System), which delivers 3 cm of ablation in less than 60 seconds. The technique was tested in domestic swine and six human patients. The swipe technique delivered uniform and predictable ablation with mucosal and submucosal necrosis in animal and human esophagus. All the animals tolerated the ablations without difficulty and were able to eat and gain weight afterward. The human patients also tolerated the procedure without adverse events. Investigators concluded that because of its ease of use, the device merits further clinical study in treating dysplastic Barrett's esophagus. "These studies reinforce C2 Therapeutics' commitment to improving treatment for patients affected by Barrett's esophagus and other diseases of the gastrointestinal system," said Peter Garcia-Meza, President and CEO. "We continue to develop new design configurations to treat unmet needs in patients with diverse anatomy and disease characteristics. We sincerely appreciate the dedication and support of our collaborating study investigators and participating trial centers." Barrett's esophagus develops as a result of chronic injury from gastroesophageal reflux disease (GERD). Over time, the normal esophageal lining is replaced with abnormal cells (Barrett's esophagus), putting patients at greater risk of developing cancer of the esophagus. Founded in 2007 and headquartered in Redwood City, California, C2 Therapeutics developed the C2 CryoBalloon® Ablation System for use as a cryosurgical tool in the field of general surgery, specifically for endoscopic applications, to include ablation of Barrett's esophagus with dysplasia. Acquired by PENTAX Medical – a division of HOYA Group – in January 2017, C2 Therapeutics continues to innovate and enhance its C2 CryoBalloon® Ablation System as a new standard for simplicity in the eradication of esophageal disease. For more information about C2 Therapeutics, please visit www.c2therapeutics.com. 1 George Kunnackal John, et al, Cryoballoon Ablation for Barrett's Esophagus: A Prospective Single Operator Learning Curve and Time-Efficiency Study, TU1170, AB560 GASTROINTESTINAL ENDOSCOPY Volume 85, No. 5S, 2017. 2 Sanne N. van Munster, et al, Post-Procedure Pain Associated with Endoscopic Ablation Therapy of Barrett's Esophagus: Post-Hoc Comparison Between Radiofrequency Ablation and Cryoballoon Ablation, TU1186, AB560 GASTROINTESTINAL ENDOSCOPY Volume 85, No. 5S, 2017. 3 Yan Ke, et al, Safety and Efficacy of Endoscopic Focal Cryoballoon Ablation for the Treatment of Esophageal Squamous Cell Intraepithelial Neoplasia, M01997, AB560 GASTROINTESTINAL ENDOSCOPY Volume 85, No. 5S, 2017. 4 Anish Patel, et al, Endoscopic Management of Refractory Gastric Antral Vascular Ectasia (GAVE) with Cryoballoon Therapy: A Case Series, MO1986, AB560 GASTROINTESTINAL ENDOSCOPY Volume 85, No. 5S, 2017. 5 Brian E. Louie, et al, Evaluation of a Novel Swipe Cryoballoon Ablation System in Bench, Porcine, and Human Esophagus, MO2010, AB560 GASTROINTESTINAL ENDOSCOPY Volume 85, No. 5S, 2017. i C2 CryoBalloon Focal Ablation System is intended for use as a cryosurgical tool in the field of general surgery, specifically for endoscopic applications, to include ablation of Barrett's esophagus with dysplasia.


The CbAS is similar to RFA in being deployed with an endoscopic catheter but uses extreme cold instead of heat to destroy diseased tissue in the esophagus. In a procedure known as cryoballoon ablation, nitrous oxide (N 0) cryogen is delivered through a handheld controller in combination with a self-sizing balloon catheter that is inserted into the working channel of a 3.7 mm therapeutic endoscope. The CbAS has been used in nearly 900 procedures to date. The synopses of the study results released for Digestive Disease Week are: Physician Learning Curve. Studies show that physicians must perform about 30 RFA procedures to overcome the effect of learning curve on treatment outcomes.1 This study aimed to determine the learning threshold for ablation of Barrett's esophagus with the CbAS. The researchers analyzed prospectively collected cryoablation procedure data from patients with neoplastic Barrett's esophagus treated at a single academic institution. They concluded that the learning curve effect for CbAS is reached at about 18 cases, after which efficiency plateaus. Patient Experience. Two studies in the Netherlands2 compared post-procedural pain in 79 Barrett's esophagus patients treated with RFA patients and 20 treated with focal cryoballoon ablation. In both studies, all visible Barrett's esophagus was treated, including circumferential treatment of the gastroesophageal junction. Pain was assessed immediately after the procedures and by telephone on Day 2. Patients were asked to apply pain scores from zero (no pain) to 10 (worst pain possible). Immediately after the procedure, 53% of cryoballoon ablation patients reported severe pain (score greater than 3), versus 24% of RFA patients. However, on Day 2, 46% of RFA patients reported severe pain, versus 18% of cryoballoon ablation patients. "This could suggest a shortened pain course after cryoballoon ablation compared with RFA," said the principal investigator Prof. Bas Weusten, Gastroenterology & Hepatology, St. Antonius Hospital, Nieuwegein, Netherlands. Treatment for ESCN. Esophageal squamous cell cancer arises from esophageal squamous cell neoplasia (ESCN) and is highly lethal. A multi-site study3 assessed the safety and efficacy of focal cryoballoon ablation for eradicating ESCN. Forty-two patients (98%) were successfully treated. Thirty-five of 40 patients (88%) had complete eradication of unstained lesions (USL) upon a single treatment session; five patients (12%) with persistent USL were successfully re-treated. Three developed superficial self-limited mucosal laceration upon balloon inflation; two of these were successfully treated three months later and one did not return. Dr. Gui-Qi Wang, Department of Endoscopy, Cancer Institute and Hospital Chinese Academy of Medical Sciences in Beijing, China stated, "Although longer-term follow-up data is pending, early results of our multicenter study suggest that focal cryoballoon ablation is safe, well-tolerated and highly effective in inducing complete endoscopic and histologic response." Treatment for GAVE. GAVE is an uncommon cause of upper gastrointestinal bleeding. Endoscopic management has been mainly thermoablative, but balloon cryoablation is emerging as an alternative. This multi-center study4 reviewed data from 10 patients with refractory GAVE who were treated with balloon cryotherapy. These were patients who continued to receive treatment for GAVE despite prior non-cryoballoon therapy. Each patient received one to four cryoballoon treatments (median two). Technical success was achieved in all patients. Follow-up endoscopy showed improvement in eight patients; one patient showed no improvement in the three months post-cryotherapy. No adverse events were reported. "Cryoballoon therapy is a feasible and safe modality that can be used to treat GAVE," reports Dr. Amrita Sethi, Division of Digestive and Liver Disease, Columbia University Medical Center, New York, NY. "Further studies are needed to evaluate long-term outcomes for this modality and to compare results to standard therapies." Swipe Cryoballoon Ablation Technique. Ablation devices for dysplastic Barrett's esophagus are effective, but none offer the attributes for widespread adoption because of length of procedure time and ease of use. Other factors include side effects and lack of predictability of ablation depth. This multi-center study5 evaluated the safety, feasibility and dose response of a novel swipe balloon catheter developed by C2 Therapeutics (to be marketed as the C2 CryoBalloon® 90 Ablation System), which delivers 3 cm of ablation in less than 60 seconds. The technique was tested in domestic swine and six human patients. The swipe technique delivered uniform and predictable ablation with mucosal and submucosal necrosis in animal and human esophagus. All the animals tolerated the ablations without difficulty and were able to eat and gain weight afterward. The human patients also tolerated the procedure without adverse events. Investigators concluded that because of its ease of use, the device merits further clinical study in treating dysplastic Barrett's esophagus. "These studies reinforce C2 Therapeutics' commitment to improving treatment for patients affected by Barrett's esophagus and other diseases of the gastrointestinal system," said Peter Garcia-Meza, President and CEO. "We continue to develop new design configurations to treat unmet needs in patients with diverse anatomy and disease characteristics. We sincerely appreciate the dedication and support of our collaborating study investigators and participating trial centers." Barrett's esophagus develops as a result of chronic injury from gastroesophageal reflux disease (GERD). Over time, the normal esophageal lining is replaced with abnormal cells (Barrett's esophagus), putting patients at greater risk of developing cancer of the esophagus. Founded in 2007 and headquartered in Redwood City, California, C2 Therapeutics developed the C2 CryoBalloon® Ablation System for use as a cryosurgical tool in the field of general surgery, specifically for endoscopic applications, to include ablation of Barrett's esophagus with dysplasia. Acquired by PENTAX Medical – a division of HOYA Group – in January 2017, C2 Therapeutics continues to innovate and enhance its C2 CryoBalloon® Ablation System as a new standard for simplicity in the eradication of esophageal disease. For more information about C2 Therapeutics, please visit www.c2therapeutics.com. 1 George Kunnackal John, et al, Cryoballoon Ablation for Barrett's Esophagus: A Prospective Single Operator Learning Curve and Time-Efficiency Study, TU1170, AB560 GASTROINTESTINAL ENDOSCOPY Volume 85, No. 5S, 2017. 2 Sanne N. van Munster, et al, Post-Procedure Pain Associated with Endoscopic Ablation Therapy of Barrett's Esophagus: Post-Hoc Comparison Between Radiofrequency Ablation and Cryoballoon Ablation, TU1186, AB560 GASTROINTESTINAL ENDOSCOPY Volume 85, No. 5S, 2017. 3 Yan Ke, et al, Safety and Efficacy of Endoscopic Focal Cryoballoon Ablation for the Treatment of Esophageal Squamous Cell Intraepithelial Neoplasia, M01997, AB560 GASTROINTESTINAL ENDOSCOPY Volume 85, No. 5S, 2017. 4 Anish Patel, et al, Endoscopic Management of Refractory Gastric Antral Vascular Ectasia (GAVE) with Cryoballoon Therapy: A Case Series, MO1986, AB560 GASTROINTESTINAL ENDOSCOPY Volume 85, No. 5S, 2017. 5 Brian E. Louie, et al, Evaluation of a Novel Swipe Cryoballoon Ablation System in Bench, Porcine, and Human Esophagus, MO2010, AB560 GASTROINTESTINAL ENDOSCOPY Volume 85, No. 5S, 2017. i C2 CryoBalloon Focal Ablation System is intended for use as a cryosurgical tool in the field of general surgery, specifically for endoscopic applications, to include ablation of Barrett's esophagus with dysplasia.


News Article | May 9, 2017
Site: www.prweb.com

USLegalForms.com is turning 20 and to commemorate the occasion, the top ranked legal forms website is running a limited-time promotion to help consumers better organize their legal affairs. The company is giving the public a free legal and financial documents inventory form. The form normally retails for $14.95. U.S. Legal Forms is also offering its life documents planning package for $20. It contains state-specific legal documents including Will, Living Will, and Power of Attorney forms and represents a more than 50% discount off normal pricing. The promotion runs through May 31, 2017 and can be accessed at http://www.uslegalforms.com/20. “For the past two decades, USLegalForms.com has operated and maintained the most comprehensive database of state-specific legal forms online,” said U.S. Legal Forms CEO Frank D. Edens. “We have seen steady growth and been successful over the years because of our loyal customers and we wanted to take a moment and give back.” Edens founded MSLegalForms.com in 1997. It was soon rebranded USLegalForms.com. During an era when dotcoms have come and gone, USLegalForms.com has increased its web database to more than 85,000 legal forms and earned its reputation as an industry leader. For the past eleven consecutive years in a row, USLegalForms.com has been recognized as the best legal forms company by Top Ten Reviews in all categories, including forms, features, customer service and ease of use. It has also been nationally endorsed by financial radio talk show host Dave Ramsey for more than a decade. “Our mission remains to help attorneys to conduct their businesses more efficiently and also to assist the public and small business owners with routine legal document needs,” Edens said. For more information, please visit https://www.uslegalforms.com. USLegal, Inc. is a multi-faceted legal publishing company which provides online legal solutions for attorneys, small businesses, and consumers. Its web properties include USLegal.com, USLegalForms.com, and FormsPass.com. Founded in 1997 and nationally endorsed by financial radio talk show host Dave Ramsey, USLegalForms.com has earned its reputation as the largest, oldest, and most acclaimed source for downloadable legal forms on the Internet. USLegal has also been recognized as the best legal forms company from 2006-2017 by Top Ten Reviews in all categories, including forms, features, customer service and ease of use. Visit USLegal.com now to find out more about our products and services.


News Article | February 15, 2017
Site: www.prweb.com

RIC Insurance General Agency has announced that Travis Campbell has been hired as a Senior Broker to expand our E&S Division, working primarily with retail insurance agents in Orange, San Diego, and Imperial Counties. Prior to joining RIC, Campbell worked as a Broker at USG Insurance Services, Inc., specializing in oil and gas, construction, habitation, hospitality, environmental, products and manufacturing, professional, medical, and healthcare coverage. As a broker at Sloan Mason Insurance Services, he focused on helping retail agents place business in oil and gas, environmental risks, and marine specialties, including USL&H and MEL. Before that, he worked as a retail producer at Olin Hill and Associates, specializing in commercial lines. “With ten years of experience as a retail agent, I understand what it takes to find competitive options for clients,” says Campbell. “I look forward to developing productive relationships with RIC agents and helping them place challenging E&S accounts.” “Travis brings a wealth of experience to the position, having spent more than a decade focused on finding optimal coverage for high-risk accounts,” says Tom Clansen, Senior Vice President, Commercial Brokerage & Underwriting at RIC. “We have confidence that he will be a valuable asset to our retail agents and carrier partners.” RIC Insurance General Agency is a wholesale insurance brokerage and managing general agency with office locations across the western United States. Its product offerings include Commercial Admitted, Specialty / Excess and Surplus, Workers Compensation, Commercial Auto and Garage Liability, and Personal Lines. For more information, please visit ric-ins.com.


News Article | February 28, 2017
Site: www.prnewswire.co.uk

Awards for Best Viral Marketing Campaign and Best Digital Marketing Campaign for the Year 7EDGE won the Best Viral Marketing Campaign and Best Digital Marketing Campaign awards at BBC Knowledge National Digital Marketing Awards. These awards were won for 'Save Bengaluru-Select a Good Corporator for Namma Bengaluru Foundation' and 'Yaari Nibhao Jeet Manao for McDowell's No1 Soda' respectively. The awards were held at Taj Land's End, Mumbai on 13th February 2017. Commenting on these wins, Mr. Ashu Kajekar, CEO, 7EDGE said, "We are delighted to have picked up two awards at the BBC Digital Knowledge - National Digital Marketing Conference & Awards. We are delighted that both our campaigns that saw an immense reach and impact among the audiences have gained this prestigious recognition. For me and the team at 7EDGE, it's a reaffirmation of our belief in the Internet First philosophy that has and will help us deliver exceptional value to our clients across geographies." Mr. Subroto Geed, Senior Vice President and Portfolio Head, USL, said, "The McDowell's No1 Soda Yaari Nibhao Jeet Manao campaign created unique engagement where through multiple touchpoints, millions of fans engaged on digital media to make, watch and fulfil zaniest and whackiest 'Yaari promises' in support of their respective favourite cricket teams. 7EDGE was a wonderful partner on this journey and we are happy that the great work around the campaign has been awarded this recognition." The McDowell's No.1 Soda campaign saw key roles played by DDB Mudra, the Creative Agency, Mindshare, the Media House, and Elements MediaWorks, the Production House. " Bangalore in 2015 needed to make the right choice. Getting the people of the city to do so needed some out-of-the-box thinking. With the help of 7EDGE, we were successful in creating a campaign that resonated with the urban audience of the city. It was a pleasure to see technology amplify the outreach of our call for citizen involvement in improving the governance of our city. Winning the award in the Best Viral Campaign category defines how far its reach was," said Mr. Sridhar Pabbisetty, CEO - Namma Bengaluru Foundation. The campaign also saw key roles played by installation Artist, M S Pushparaj and Video Production House, Kalveer.com. The BBC Knowledge Digital Marketers' Awards are designed to recognize exceptional work done by the marketing fraternity to take their brands into the digital era. These awards recognize and reward leaders for the pioneering job of online asset creation amongst their peer-set for their brands. The entries are judged by an exceptional jury who not only look at results but also the leadership ability in creating an innovative marketing environment that has the ability to change the game for the branding and marketing industry. The winning campaign videos can be viewed here: About 7EDGE - The Internet First Company 7EDGE Internet Private Limited is an Internet First company enabling Internet journeys of brands and businesses through its delivery portfolio comprising Internet-based consulting services and strategic solutions that are in line with the best of Internet trends and technologies. 7EDGE believes in its ability to strategise, solve, and scale, thus enabling enterprises, start-ups, and entrepreneurs seeking product incubation across various geographies in a range of industries. 7EDGE delivers on its Internet First philosophy through its expertise in programmatic media buying, marketing cloud, SMAC (Social, Mobile, Analytics & Cloud), automation, digitisation, digitalisation, digital transformation, and artificial intelligence to help organizations harness the true potential of the Internet for business outcomes. Founded in 2010 and based out of Bengaluru, 7EDGE has a global reach. The company has engaged with over 60 companies and 80+ brands across India, Malaysia, Singapore, Nigeria, UAE, and the US in the areas of Strategic Consulting, Digital Marketing, Digital Media, Web & Mobility, DevOps, Big Data, and Internet of Things. Know more at http://www.7edge.com


News Article | February 15, 2017
Site: www.prweb.com

USLegal, Inc. today announced a partnership with ArbiClaims, a premier web-based dispute resolution service. The alliance now enables individuals to settle legal disagreements more quickly, efficiently, and affordably though online arbitration. Arbitration is a process to resolve conflicts without going to court. An arbitrator decides a case and the decision is enforceable similar to a court judgment. The new service can be accessed at resolveit.uslegal.com. “USLegal welcomes the opportunity to partner with ArbiClaims to bring online dispute resolution to our website users. We seek to provide USLegal customers with access to the widest range of legal products and services available today, especially those that can help them settle legal matters cost effectively,” said USLegal CEO Frank D. Edens. ArbiClaims handles personal and business disputes under $15,000. Once parties agree to use the service, evidence is presented to a neutral third party arbitrator and 15 to 30 minute online “trials” are held. The decision and awards made by the arbitrator then becomes binding on the parties. Most conflicts are resolved in 21 days through the web-based service versus going through the traditional court process which can often take months and involve the hiring of attorneys and payment of court costs to resolve. Examples of matters that can be handled by ArbiClaims include disagreements over loan repayments, past due invoices, car repair, security deposits, and services contracts. "US Legal is a proven leader in DIY law, having provided millions of users with cost effective solutions they otherwise wouldn't have access to,” said Stephen Kane, ArbiClaims CEO. “We're excited to partner with them and work together to do the same thing when it comes to disputes. Frank and his team understand the pain points we solve with ArbiClaims, making them a natural fit." For more information, please visit resolveit.uslegal.com. USLegal, Inc. is a multi-faceted legal publishing company which provides online legal solutions for attorneys, small businesses, and consumers. Its web properties include USLegal.com, USLegalForms.com, FormsPass.com, and more. USLegalForms.com is the largest, oldest, and most acclaimed source for downloadable legal forms on the Internet. USLegalForms.com has been recognized as the best legal forms company from 2006-2016 by Top Ten Reviews in all categories, including forms, features, customer service and ease of use. For more information, visit http://www.uslegalforms.com. USLegal has maintained an active presence on the Internet as a legal publisher since 1997. Traffic to USLegal websites exceed 2 million unique visitors per month. Its assets include an attorney directory with more than 40,000 attorneys listed. For more information, visit http://www.uslegal.com. ArbiClaims is a premier web-based dispute resolve service. Its mission is to make it easy to resolve disputes, regardless of access to legal counsel or other resources; and to dramatically increase access to justice. For more information, visit https://www.arbiclaims.com.


News Article | February 15, 2017
Site: www.prweb.com

USLegal, Inc., which owns top domains including USLegal.com, USLegalForms.com, and FormsPass.com, today announced two key additions to its senior leadership team. Carrie Anna Criado has joined the company as an attorney and Chief Marketing and Communications Officer and Edward Tyler has come aboard as Director of Partnership Alliances. Both bring a wealth of experience in the media industry and in marketing, branding, content, and website development. “Carrie and Ed have joined USLegal at a pivotal time for the company,” said USLegal CEO Frank D. Edens. “We have been in business for almost 20 years providing online legal solutions for attorneys, small businesses, and consumers. As we get ready to evolve our business and expand product and service offerings, their roles will be crucial to our future success.” At USLegal, Criado will lead marketing and advertising efforts, develop strategic communications plans, and oversee media and public relations initiatives. She will also work on website content, product development, brand development, and social media. The move marks Criado’s return to USLegal where she had previously served as a staff attorney and Director of Public Relations for the company. Most recently, she was Assistant Dean of Communications and Marketing at the University of Houston Law Center. Criado has also served as Communications Director for The Climate Project founded by Former Vice President Al Gore. She has worked as a television journalist for KVII-TV, KEYT-TV, and KUHT-TV and was a national TV field producer for The First Amendment Center at Vanderbilt. Criado received a B.A. in Journalism from the University of Texas at Austin and earned her J.D. at the University of Houston Law Center. Criado is licensed to practice law in Texas and Tennessee. Tyler comes to USLegal as a seasoned senior management executive with a media industry career that spans 38 years. In his role as Director of Partnership Alliances, he will focus on building strategic relationships and business development. Tyler has been part of the executive teams that developed and launched 13 new media brands including Car Audio, Law Technology, MetalWorking Digest and GSN Magazine for the homeland security industry to name a few. He honed his career in top media companies including, Hearst, New York Law, Curtco, Cygnus and for the last 13 years, ran World Business Media, LLC, a media company he founded and has since sold. For more information, please visit https://corporate.uslegal.com/management-team/. USLegal, Inc. is a multi-faceted legal publishing company which provides online legal solutions for attorneys, small businesses, and consumers. Its web properties include USLegal.com, USLegalForms.com, FormsPass.com, and more. USLegalForms.com is the largest, oldest, and most acclaimed source for downloadable legal forms on the Internet. USLegalForms.com has been recognized as the best legal forms company from 2006-2016 by Top Ten Reviews in all categories, including forms, features, customer service and ease of use. For more information, visit http://www.uslegalforms.com. USLegal has maintained an active presence on the Internet as a legal publisher since 1997. Traffic to USLegal websites exceed 2 million unique visitors per month. Its assets include an attorney directory with more than 40,000 attorneys listed. For more information, visit http://www.uslegal.com.

Loading USL collaborators
Loading USL collaborators